Roumell Asset Management, LLC Enzo Biochem Inc Transaction History

Roumell Asset Management, LLC

$51 Million
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$1.84 - $2.66 $412,075 - $595,717	-223,954 Reduced 24.74%	681,358 $1.25 Million
Q1 2023 May 12, 2023	SELL	$1.0 - $2.51 $1.22 Million - $3.07 Million	-1,222,952 Reduced 57.46%	905,312 $2.2 Million
Q4 2022 Feb 13, 2023	SELL	$1.16 - $2.42 $303,858 - $633,911	-261,947 Reduced 10.96%	2,128,264 $3.04 Million
Q2 2022 Aug 12, 2022	SELL	$2.0 - $3.0 $4,862 - $7,293	-2,431 Reduced 0.1%	2,390,211 $4.95 Million
Q1 2022 May 13, 2022	SELL	$2.9 - $3.47 $127,974 - $153,127	-44,129 Reduced 1.81%	2,392,642 $6.94 Million
Q4 2021 Feb 11, 2022	SELL	$3.17 - $4.09 $1.43 Million - $1.84 Million	-450,000 Reduced 15.59%	2,436,771 $7.82 Million
Q2 2021 Aug 13, 2021	BUY	$2.86 - $3.61 $429,148 - $541,687	150,052 Added 5.48%	2,886,771 $9.15 Million
Q1 2021 May 14, 2021	SELL	$2.61 - $4.08 $85,503 - $133,660	-32,760 Reduced 1.18%	2,736,719 $9.41 Million
Q4 2020 Feb 16, 2021	BUY	$1.82 - $2.61 $755,300 - $1.08 Million	415,000 Added 17.63%	2,769,479 $6.98 Million
Q3 2020 Nov 13, 2020	BUY	$2.02 - $3.02 $3.52 Million - $5.26 Million	1,742,715 Added 284.87%	2,354,479 $4.97 Million
Q2 2020 Aug 14, 2020	BUY	$2.12 - $3.22 $1.3 Million - $1.97 Million	611,764 New	611,764 $1.37 Million
Q3 2019 Nov 13, 2019	SELL	$3.01 - $4.0 $3.72 Million - $4.95 Million	-1,236,309 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$2.79 - $4.31 $1.85 Million - $2.86 Million	-662,870 Reduced 34.9%	1,236,309 $4.17 Million
Q1 2019 May 14, 2019	BUY	$2.54 - $4.02 $2.02 Million - $3.19 Million	794,040 Added 71.85%	1,899,179 $5.19 Million
Q4 2018 Feb 14, 2019	BUY	$2.46 - $4.2 $836,043 - $1.43 Million	339,855 Added 44.41%	1,105,139 $3.07 Million
Q3 2018 Nov 13, 2018	BUY	$3.81 - $5.53 $2.92 Million - $4.23 Million	765,284 New	765,284 $3.15 Million

Others Institutions Holding ENZ

# of Institutions

Shares Held

15.4M

Call Options Held

2.3K

Put Options Held

Harbert Fund Advisors, Inc. Birmingham, AL

5.18M
Shares

$3.42 Million
3.43% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.53M
Shares

$1.67 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.88M
Shares

$1.24 Million
0.0% of portfolio
Potomac Capital Management, Inc.

1.48M
Shares

$977,949
3.63% of portfolio
Viex Capital Advisors, LLC Sunny Isles Beach, FL

1.33M
Shares

$880,756
9.62% of portfolio

View Full List

About ENZO BIOCHEM INC

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $32.2M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

More about ENZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roumell Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roumell Asset Management, LLC with notifications on news.

Account